← Evidence map

ArticleBioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy2025

An Automated Tool for Glycosimilarity Assessment of mAb Therapeutic Biosimilars: Trastuzumab and Bevacizumab as Case Studies.

Anuj Shrivastava et al.PubMed ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2025
2026
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 39873867